98%
921
2 minutes
20
The highly homologous type III antifreeze protein (AFP) subfamily share the capability to inhibit ice growth at subzero temperatures. Extensive studies by X-ray crystallography have been conducted, mostly on AFPs from polar fishes. Although interactions between a defined flat ice-binding surface and a particular lattice plane of an ice crystal have now been identified, the fine structural features underlying the antifreeze mechanism still remain unclear owing to the intrinsic difficulty in identifying H atoms using X-ray diffraction data alone. Here, successful perdeuteration (i.e. complete deuteration) for neutron crystallographic studies of the North Atlantic ocean pout (Macrozoarces americanus) AFP in Escherichia coli high-density cell cultures is reported. The perdeuterated protein (AFP D) was expressed in inclusion bodies, refolded in deuterated buffer and purified by cation-exchange chromatography. Well shaped perdeuterated AFP D crystals have been grown in D(2)O by the sitting-drop method. Preliminary neutron Laue diffraction at 293 K using LADI-III at ILL showed that with a few exposures of 24 h a very low background and clear small spots up to a resolution of 1.85 A were obtained using a ;radically small' perdeuterated AFP D crystal of dimensions 0.70 x 0.55 x 0.35 mm, corresponding to a volume of 0.13 mm(3).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664773 | PMC |
http://dx.doi.org/10.1107/S1744309109008574 | DOI Listing |
Rev Sci Instrum
September 2025
HUN-REN Centre for Energy Research, Budapest, Hungary.
A novel medium-current (up to 20 mA), low normalized beam emittance (<1 π mm mrad) electron cyclotron resonance microwave H+ ion source has been developed at the Center for Energy Research in Budapest, Hungary. This high-stability design targets an energy ripple below 1% while delivering a continuous or pulsed proton beam with adjustable pulse duration (0.1-10 ms) and frequency (0.
View Article and Find Full Text PDFJ Am Chem Soc
August 2025
Frontiers Science Center for Transformative Molecules, Center for Chemical Glycobiology, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, State Key Laboratory of Synergistic Chem-Bio Synthesis, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 20
Boron neutron capture therapy (BNCT) is a promising and selective strategy for treating aggressive and refractory tumors, but its clinical success depends on the development of effective boron delivery agents. These agents must offer high tumor selectivity, structural stability, and sufficient boron content─criteria that current clinical options fail to fully satisfy. Herein, we report a visible-light-driven decarboxylative B-C cross-coupling between boron-functionalized carborane carboxylic acids and dehydroalanine (Dha)-containing peptides, enabling the first synthesis of boron-vertex-substituted carboranyl peptides under mild conditions.
View Article and Find Full Text PDFCancer Biother Radiopharm
August 2025
Department of Radiation Oncology, The First Hospital of Lanzhou University, Lanzhou, China.
Boron neutron capture therapy (BNCT) is a precision binary radiotherapy. In this modality, thermal neutrons combine with 10B to induce a nuclear reaction that kills tumor cells. Its therapeutic efficacy depends on the targeted accumulation of boron delivery agents.
View Article and Find Full Text PDFPharmaceuticals (Basel)
June 2025
Department of Pharmaceutical Sciences, University of Eastern Piedmont, Largo Guido Donegani, 2, 28100 Novara, Italy.
Boron Neutron Capture Therapy (BNCT) is a promising cancer treatment that combines tumor-selective boron delivery agents with thermal neutrons to kill cancer cells while sparing normal tissue. BNCT requires boron-containing compounds that exhibit high tumor selectivity and achieve therapeutic boron concentrations within tumor cells. This work focuses on the early development of a novel boron cluster carbohydrate derivative based on the glucosamine structure.
View Article and Find Full Text PDFAppl Radiat Isot
November 2025
Kindai University Atomic Energy Research Institute, Kindai University, Osaka, Japan.
Boron neutron capture therapy (BNCT) is a promising cancer treatment method that utilizes the nuclear reaction between B and thermal neutrons. Three-dimensional (3D) gel dosimeters are gaining attention for their potential to assess 3D dose distributions in BNCT. In this study, a PVA-GTA-I (polyvinyl alcohol crosslinked by glutaraldehyde, and iodide) radiochromic gel dosimeter, which develops a red color due to complex formation between PVA and iodide, was investigated.
View Article and Find Full Text PDF